Published in J Comput Chem on June 06, 2011
Comparing the Chemical Structure and Protein Content of ChEMBL, DrugBank, Human Metabolome Database and the Therapeutic Target Database. Mol Inform (2013) 1.29
iGPCR-drug: a web server for predicting interaction between GPCRs and drugs in cellular networking. PLoS One (2013) 0.94
PharmaTrek: A Semantic Web Explorer for Open Innovation in Multitarget Drug Discovery. Mol Inform (2012) 0.89
iEzy-drug: a web server for identifying the interaction between enzymes and drugs in cellular networking. Biomed Res Int (2013) 0.85
Comment on the paper "indexing molecules with chemical graph identifiers" by Elisabeth Gregori-Puigjané, Rut Garriga-Sust, and Jordi Mestres. J Comput Chem (2011) 0.75
Many InChIs and quite some feat. J Comput Aided Mol Des (2015) 0.75
Data completeness--the Achilles heel of drug-target networks. Nat Biotechnol (2008) 2.18
Identification of pim kinases as novel targets for PJ34 with confounding effects in PARP biology. ACS Chem Biol (2012) 1.07
Scientific competency questions as the basis for semantically enriched open pharmacological space development. Drug Discov Today (2013) 1.04
A chemogenomic approach to drug discovery: focus on cardiovascular diseases. Drug Discov Today (2009) 0.99
A ligand-based approach to mining the chemogenomic space of drugs. Comb Chem High Throughput Screen (2008) 0.99
Guided docking approaches to structure-based design and screening. Curr Top Med Chem (2004) 0.98
Anticipating drug side effects by comparative pharmacology. Expert Opin Drug Metab Toxicol (2010) 0.98
Automatic filtering and substantiation of drug safety signals. PLoS Comput Biol (2012) 0.96
The EU-ADR Web Platform: delivering advanced pharmacovigilance tools. Pharmacoepidemiol Drug Saf (2012) 0.95
Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1. J Virol (2012) 0.95
Chemical and biological profiling of an annotated compound library directed to the nuclear receptor family. Curr Top Med Chem (2005) 0.94
iPHACE: integrative navigation in pharmacological space. Bioinformatics (2010) 0.93
SHED: Shannon entropy descriptors from topological feature distributions. J Chem Inf Model (2006) 0.92
Coverage and bias in chemical library design. Curr Opin Chem Biol (2008) 0.91
PharmaTrek: A Semantic Web Explorer for Open Innovation in Multitarget Drug Discovery. Mol Inform (2012) 0.89
Chemical probes for biological systems. Drug Discov Today (2010) 0.89
Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system. PLoS One (2013) 0.88
Prediction of the P. falciparum target space relevant to malaria drug discovery. PLoS Comput Biol (2013) 0.87
FCP: functional coverage of the proteome by structures. Bioinformatics (2006) 0.85
Certification of occupational diseases as common diseases in a primary health care setting. Am J Ind Med (2005) 0.85
Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors. Oncotarget (2014) 0.85
Ligand-based approaches to in silico pharmacology. Methods Mol Biol (2011) 0.85
Distant polypharmacology among MLP chemical probes. ACS Chem Biol (2014) 0.84
Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors. Bioorg Med Chem Lett (2010) 0.84
Applied information retrieval and multidisciplinary research: new mechanistic hypotheses in complex regional pain syndrome. J Biomed Discov Collab (2007) 0.83
Cross-pharmacology analysis of G protein-coupled receptors. Curr Top Med Chem (2011) 0.83
Myxobacteria: natural pharmaceutical factories. Microb Cell Fact (2012) 0.83
Multi-targeted activity of maslinic acid as an antimalarial natural compound. FEBS J (2011) 0.83
Design of a general-purpose European compound screening library for EU-OPENSCREEN. ChemMedChem (2014) 0.83
Mutual induced fit in cyclodextrin-rocuronium complexes. Org Biomol Chem (2005) 0.82
In silico directed chemical probing of the adenosine receptor family. Bioorg Med Chem (2010) 0.82
Unsupervised guided docking of covalently bound ligands. J Comput Aided Mol Des (2004) 0.82
A chemocentric approach to the identification of cancer targets. PLoS One (2012) 0.81
Identification of small molecule inhibitors of amyloid β-induced neuronal apoptosis acting through the imidazoline I(2) receptor. J Med Chem (2012) 0.80
A canonical cation-π interaction stabilizes the agonist conformation of estrogen-like nuclear receptors. Eur Biophys J (2010) 0.77
Exploring the effect of PARP-1 flexibility in docking studies. J Mol Graph Model (2013) 0.76
Shaping the future of safer innovative drugs in Europe. Nat Biotechnol (2011) 0.75
Chemoisosterism in the proteome. J Chem Inf Model (2013) 0.75
Polypharmacology in Precision Oncology: Current Applications and Future Prospects. Curr Pharm Des (2016) 0.75
Editorial: Sustained Success of Molecular Informatics. Mol Inform (2013) 0.75
Editorial: Molecular Informatics Gaining Impact. Mol Inform (2012) 0.75
Molecular Informatics Going "Fully Online". Mol Inform (2014) 0.75
Molecular Informatics - From Models to Molecules and Systems. Mol Inform (2010) 0.75
Systems Approaches and Big Data in Molecular Informatics. Mol Inform (2015) 0.75
Molecular Informatics: From Models to Systems and Beyond. Mol Inform (2016) 0.75
New chromene scaffolds for adenosine A(2A) receptors: synthesis, pharmacology and structure-activity relationships. Eur J Med Chem (2012) 0.75
Correction to Insights from Fragment Hit Binding Assays by Molecular Simulations. J Chem Inf Model (2016) 0.75
Molecular Informatics - The First Year. Mol Inform (2011) 0.75
Connecting small molecules to nuclear receptor pathways. Curr Top Med Chem (2007) 0.75
Exploring the active site of human factor Xa protein by NMR screening of small molecule probes. Org Biomol Chem (2003) 0.75